KCM

Knoll Capital Management Portfolio holdings

AUM $141M
1-Year Est. Return 51.8%
This Quarter Est. Return
1 Year Est. Return
+51.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$193M
AUM Growth
-$4.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$5.95M
2
+$1.45M
3
+$746K
4
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$431K
5
NRX
NEPHROGENEX INC COM
NRX
+$412K

Top Sells

1
+$13.2M
2
+$2.07M
3
+$720K
4
ECTE
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
+$47.5K

Sector Composition

1 Healthcare 23.61%
2 Technology 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$147M 75.94%
4,559,038
-409,164
2
$18.8M 9.74%
9,881
+3,124
3
$12.5M 6.45%
98,143
4
$3.5M 1.81%
155
5
$3.41M 1.76%
200,000
6
$2.2M 1.14%
8,604
7
$1.45M 0.75%
+200,300
8
$1.36M 0.7%
8,507
9
$809K 0.42%
20,410
+10,877
10
$746K 0.39%
+361
11
$706K 0.37%
15,000
12
$412K 0.21%
+50,000
13
$240K 0.12%
5,000
-15,000
14
$151K 0.08%
+116
15
$141K 0.07%
112,500
16
$86K 0.04%
28,630
-15,815
17
– –
-893,600
18
– –
0